SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Springview Holdings Ltd. engages in the design and construction of residential and commercial buildings. It involves new construction, reconstruction, alterations, and other general contracting services. The company was founded in 2002 and is headquartered in Singapore.

Springview Holdings Ltd - Ordinary Shares - Class A

Springview Holdings Ltd

Springview Holdings (SPHL) is seeing massive trading interest following announcements of an exclusive global license for Emesyl and a solar-ready homes partnership in Singapore. The stock's ultra-low float has ignited intense community discussion around a potential short squeeze, drawing comparisons to other high-volatility micro-cap runners. Traders are actively navigating reported broker buying restrictions and concerns about potential dilution amidst the rapid surge.

Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.

Regentis Biomaterials Ltd.

Regentis Biomaterials

Regentis Biomaterials (RGNT) is trending as a recent IPO with a notably low float, attracting significant attention after securing a new U.S. patent for its GelrinC liquid formulation. The community is actively discussing the potential for a short squeeze due to the tight float and recent news, with many observing strong price action and anticipating further upward momentum as it gains more volume.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF (DIA) is trending amidst heightened market volatility, primarily driven by the Department of Justice's criminal probe into Fed Chair Jerome Powell. This unprecedented event, coupled with an awaited Supreme Court ruling on tariffs and rising geopolitical tensions, is sparking intense community debate regarding central bank independence and broader market stability. Investors are keenly watching these significant political and economic catalysts for their potential impact on major indices and overall risk sentiment.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending amidst reports of significant price increases for its high-capacity 3D NAND enterprise SSDs, driven by surging AI-related demand and a broader memory supercycle. The community is actively debating whether the stock's explosive gains reflect its new AI leader status or an unsustainable, speculative bubble. This intense discussion is further fueled by ongoing analyst upgrades across the semiconductor sector.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is trending due to recent U.S. actions regarding Venezuela and the subsequent intense debate over its vast oil reserves. While some investors foresee a significant long-term opportunity for the energy giant to potentially re-enter the country, others remain cautious, citing the CEO's 'uninvestible' stance given past asset seizures and extensive infrastructure challenges. This polarized outlook is fueling market discussion around XOM's future prospects amidst evolving global oil dynamics.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

BYTE is trending with an enthusiastic community anticipating significant upward movement, largely driven by its narrative as the "Original Grok AI dog" on Ethereum. The community highlights its "no taxes, LP burned" structure and sees it as a "legacy play" within the AI meta, proclaiming it the "chosen one" with an "unstoppable" future. Sentiment remains strongly bullish, with users actively encouraging others to join the "pack" and ride its perceived momentum.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science (MLEC) is a focal point of discussion after its recent 1-for-15 reverse stock split, which dramatically reduced the available share float. The community is heavily engaged, anticipating a potential short squeeze due to the ultra-low float and drawing comparisons to other tickers that have experienced significant parabolic moves. Traders are actively watching for heightened volatility and upward momentum driven by this tight market structure.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem is trending after announcing a strategic shift to discontinue its RAMP 203 trial, focusing resources on its promising VS-7375 KRAS G12D inhibitor and RAMP 205 pancreatic cancer program. This move, alongside analyst upgrades and M&A buzz in the oncology sector, has some seeing deep value and buyout potential, while a vocal part of the community is highly frustrated by persistent stock declines, alleging manipulation and questioning management's communication.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos (XTZ) is trending amidst buzz around its advancements in the Real World Asset (RWA) sector, specifically with the recent "Uranium Tokenization Breakthrough" on its Etherlink L2 and enhanced staking accessibility. Community sentiment is sharply divided, with advocates highlighting its utility and staking rewards in anticipation of a broader altcoin season, while others express strong skepticism regarding its long-term viability and increasing supply.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending due to recent FDA safety communications concerning specific product lots, sparking community debate over its potential impact on upcoming earnings. Investors are keenly anticipating the next financial update, hoping for positive guidance on margin expansion from new production processes. Simultaneously, persistent buyout speculation continues to fuel discussions, with many long-term holders viewing current valuations as a significant buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Losers Today: $SDM $AQST $ACON $BBNX $STSS  
 
Save this screener: https://stockanalysis.com/markets/losers/?ref=saveontrading

KNOW WHO YOU FOLLOW

A list of the stocks with the highest percentage loss today. See stock price, volume, market cap and more.